CagriSema Incident: The Surprise Winner And What It Means For The Novo-Lilly Rivalry
Source: SeekingAlpha
2026-03-06 18:13:23 ET
Intro
When Novo Nordisk A/S ( NVO ) CEO Maziar "Mike" Doustdar and Eli Lilly and Company ( LLY ) CEO David Ricks stood shoulder to shoulder in the White House Oval Office during their drug pricing deal ?announcement ceremony with the Trump administration back in November, they came across almost like close allies fighting for the very same goal....
Read the full article on Seeking Alpha
For further details see:
CagriSema Incident: The Surprise Winner And What It Means For The Novo-Lilly Rivalry
Novo Nordisk A/S
NASDAQ: NVO
NVO Trading
0.57% G/L:
$38.835 Last:
8,264,234 Volume:
$38.73 Open:
NVO Latest News
March 09, 2026 12:44:07 pm
Hims & Hers Health Shares Skyrocket on Novo Nordisk Deal, but Is the Stock Still a Buy?
NVO Stock Data
$220,548,675,000
4,194,421,000
N/A
749
N/A
Biotechnology & Life Sciences
Healthcare
DK
Bagsvaerd
